🤝 Modi tells Xi: India-China need mutual sensitivity

PM Narendra Modi conveyed to Chinese President Xi Jinping that both nations must show sensitivity to each other's core concerns during their meeting. This discussion took place on the sidelines of the Brics summit last week in New Delhi. Modi stressed that border peace is essential for advancing the relationship, guided by respect and mutual interest. India's position on Tibet and Taiwan remains consistent, despite past changes in public articulation. Moving forward, the focus is on mutual respect while addressing ongoing border issues. 🤝

🎬 Mirzapur hits 200 Cr mark in 12 days

The film Mirzapur has crossed the 200 crore net mark at the Indian box office. It surpassed Akshay Kumar's Bhooth Bangla while playing in India. As of day 12, the movie earned a total of 200.52 crore, with day 12 bringing in 5.25 crore. This solid performance positions it as the 4th highest-grosser of 2026 in India. The film, released on September 4, aims for the 250 crore club next.

🎬 Drishyam 3 aims for biggest threequel opening

Drishyam 3, the fourth threequel in Ajay Devgn's franchise, is set to premiere on October 2, 2026. The film, directed by Abhishek Pathak, features Vijay Salgaonkar and stars alongside Tabu and Shriya Saran. Expectations are high as it aims to surpass Singham Again's opening of 43.70 crore. This suspense thriller is positioned to become Ajay Devgn's biggest threequel opening ever. All eyes are now on October 2 to see if records get broken at the box office. 🤩

🎬 Mandaadi overtakes Garudan as Soori's biggest hit

The Tamil sports drama Mandaadi has surpassed Garudan to become Soori’s highest grosser in a lead role. The film, which released on September 10, clashed with Sardar 2 in the box office. As of Day 6, Mandaadi has earned 50.25 crore net in India and 10.65 crore overseas. This performance marks a significant milestone for Soori, who transitioned from a character actor to a lead. The movie is directed by Pugazhendi Mathimaran and stars Soori, Suhas, and Mahima Nambiar. 🎬

🔬 New ways to fight lung infections beyond antibiotics

Researchers are exploring host-directed therapies and phages for stubborn lung infections, moving past just killing microbes. Experts discussed these novel approaches at the European Respiratory Society (ERS) 2026 Congress in Barcelona, Spain. Various agents like MMP inhibitors and anti-inflammatory drugs are being studied for different infection stages and types. Current clinical use of these advanced therapies remains low, despite strong biological backing. Future research needs standardized outcomes to properly evaluate these promising treatments. 🔬

🔬 New in-body CAR T therapy helps autoimmune diseases

An experimental in vivo CAR T therapy called JY231 showed promise in a small early-stage trial for neurologic autoimmune disorders. The therapy was administered to 16 patients across MS, MOGAD, and others at Tongji Hospital in Wuhan, China. After 6 months, patients showed reduced disability and improved function in various conditions. This method bypasses complex manufacturing and chemotherapy, making treatment potentially more accessible. Investigators plan to further study its effectiveness and safety profile moving forward. 🧠

👶 Preterm BPD Infants: Respiratory Outcomes Are Similar

Infants with bronchopulmonary dysplasia (BPD) showed comparable respiratory outcomes between extremely preterm and later preterm groups after hospital discharge. Researchers from the University of Pennsylvania studied infants with BPD born before 26 weeks between September 2018 and February 2025. The study compared 231 extremely preterm infants with 532 infants born at 24-25 6/7 weeks of gestation. Although the extremely preterm group had higher severe BPD rates, their rates of sick clinic visits and readmissions were not significantly different. This research highlights the need to better understand outpatient respiratory paths across the gestational age spectrum. 👶

🦠 COVID's long shadow: more than just a faded memory

Six years after SARS-CoV-2 was identified, COVID fear has lessened because current variants are milder and the population has built immunity. National health authorities have adjusted recommendations, now advising routine vaccination only for older adults. Despite this, the virus caused 7.1 million confirmed deaths, with WHO estimating it reached 22 million globally. Long COVID and PCS remain significant challenges, with up to 10% of symptomatic cases developing persistent symptoms. The economic impact is huge, with OECD projecting an extra $11 billion annual cost to healthcare systems. 😥

🌧️ TN set for heavy rains, temps to stay cool

Widespread rainfall is expected across Tamil Nadu until September 21 due to an active Southwest monsoon system. Dindigul district recorded the highest rainfall at 13 cm during the 24-hour period ending Tuesday morning. The Regional Meteorological Centre predicts heavy rain with gusty winds in six districts on Wednesday. This wet weather should prevent further temperature spikes in interior areas currently facing heat. The monsoon is expected to start retreating from parts of the country starting September 19. ☔

🩺 Methotrexate use in IBD: real-world findings

A new cohort study examined methotrexate use in over 1100 IBD patients outside of clinical trials. Researchers analyzed data from 15 French centers covering January 2015 to December 2022. Methotrexate was mostly used as combination therapy, with a median treatment duration of 12.3 months. While adverse events occurred, serious toxicity was uncommon in the group. The study suggests real-life data is key to understanding this treatment's role. 🩺

📚 AI model launched to boost Sanskrit heritage

The Sanskrit Heritage Model and Platform was launched at Madras Sanskrit College on Tuesday by Finance Minister Nirmala Sitharaman. The event took place in Mylapore, Chennai, in collaboration with Articul8. This new initiative aims to make literary treasures more accessible globally, referencing ancient texts. The Finance Minister stressed AI's role in helping people understand complex works like those of poet Kalidasa. The platform is designed to evolve, potentially extending its use to other Indic languages.